Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|April 30, 1990
Purification and N-terminal amino acid sequence of the tartrate-resistant acid phosphatase from human osteoclastoma: evidence for a single structureJ J Stepan, K H Lau, S Mohan, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 20, 2012
Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosisD Michalska, M Luchavova, V Zikan, et al.Life Sciences|January 1, 1991
Quantitation of growth factors in ossein-mineral-compoundJ J Stepan, S Mohan, J C Jennings, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 20, 2014
Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapyB Hofstetter, S Gamsjaeger, F Varga, et al.Annals of the Rheumatic Diseases|September 16, 2003
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal womenJ A Stakkestad, L I Benevolenskaya, J J Stepan, et al.Bone|November 10, 2016
Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix qualityE P Paschalis, S Gamsjaeger, N Hassler, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 1999
Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodiesJ M Halleen, M Karp, S Viloma, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosisJ J Stepan, D B Burr, J Li, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 12, 2012
Osteoporosis in young adults: pathophysiology, diagnosis, and managementS Ferrari, M L Bianchi, J A Eisman, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 2020
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trialJ-J Body, F Marin, D L Kendler, et al.Pageof 4